R
Roberto Sorio
Researcher at Cancer Epidemiology Unit
Publications - 145
Citations - 5710
Roberto Sorio is an academic researcher from Cancer Epidemiology Unit. The author has contributed to research in topics: Ovarian cancer & Carboplatin. The author has an hindex of 30, co-authored 139 publications receiving 5089 citations. Previous affiliations of Roberto Sorio include Hoffmann-La Roche.
Papers
More filters
Journal ArticleDOI
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
Eric Pujade-Lauraine,Felix Hilpert,Béatrice Weber,Alexander Reuss,Andreas Poveda,Gunnar B. Kristensen,Roberto Sorio,Ignace Vergote,Petronella O. Witteveen,Aristotelis Bamias,Deolinda Pereira,Pauline Wimberger,Ana Oaknin,Mansoor Raza Mirza,Philippe Follana,David T. Bollag,Isabelle Ray-Coquard +16 more
TL;DR: Adding bevacizumab to chemotherapy statistically significantly improved PFS and ORR; the OS trend was not significant.
Journal Article
Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer
Cesare Gridelli,Francesco Perrone,Ciro Gallo,Antonio Rossi,Francesco Scognamiglio,C. Guida,Silvio Monfardini,Giovanni Pietro Ianniello,Vincenza Tinessa,Maria Grazia Caprio,Antonio Santoro,Luigi Maiorino,Massimiliano Santoro,Francovito Piantedosi,L. Brancaccio,Carlo Crispino,S. Cigolari,Maria Di Lanno,Valentina Angelini,Luigi Manzione,Domenico Bilancia,Angelo Dinota,Giuseppe Failla,Rosa Anna Aiello,Paolo Tralongo,F. Figoli,Ludmilla Zuccarino,Tonino Pedicini,Antonio Febbraro,Cesira Zollo,Luciano Frontini,S. Zonato,Giuseppe Azzarello,Orazio Vinante,Federico Castiglione,Gianfranco Porcile,Alessandra Bearz,Roberto Sorio,Maurizio Tonato,S. Darwish,Enzo Veltri,M. D'Aprile,Carlo Curcio,Matteo Vasta,M. Clerici,Gino Luporini,Antonio Farris,Rosario Vincenzo Iaffaioli,Adolfo Favaretto,Giuseppe Gualtieri +49 more
TL;DR: Vinorelbine improves survival of elderly patients with advanced NSCLC and possibly improves overall quality of life (QoL) in a multicenter randomized trial that compared vinore lbine treatment with supportive care alone.
Journal ArticleDOI
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Sandro Pignata,Giovanni Scambia,Dionyssios Katsaros,Ciro Gallo,Eric Pujade-Lauraine,Sabino De Placido,Alessandra Bologna,Béatrice Weber,Francesco Raspagliesi,Pierluigi Benedetti Panici,Gennaro Cormio,Roberto Sorio,Maria Giovanna Cavazzini,Gabriella Ferrandina,Enrico Breda,V. Murgia,Cosimo Sacco,Saverio Cinieri,Vanda Salutari,Caterina Ricci,Carmela Pisano,Stefano Greggi,Rossella Lauria,Domenica Lorusso,Claudia Marchetti,Luigi Selvaggi,Simona Signoriello,Maria Carmela Piccirillo,Massimo Di Maio,Francesco Perrone +29 more
TL;DR: In this paper, a study was conducted to assess whether a weekly schedule of carboplatin plus paclitaxel is more effective than the same drugs given every 3 weeks for patients with advanced ovarian cancer.
Journal ArticleDOI
Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer
Giuseppe Toffoli,Antonio Russo,Angelo Gallo,C. Cernigoi,Silvia Miotti,Roberto Sorio,Mauro Boiocchi +6 more
TL;DR: It is investigated whether FBP in epithelial ovarian cancer specimens is a predictor of response to chemotherapy and survival, and association of FBP fluorescence index (FI) with clinical characteristics, response to chemotherapeutic regimens, and survival was studied.
Journal ArticleDOI
Hepatitis C virus and non-Hodgkin's lymphomas
Cesare Mazzaro,Vittorina Zagonel,Silvio Monfardini,P. Tulissi,Elisabetta Pussini,Massimiliano Fanni,Roberto Sorio,Roberto Bortolus,Marina Crovatto,Gianfranco Santini,Claudio Tiribelli,Franco Sasso,Roberto Masutti,Gabriele Pozzato +13 more
TL;DR: This study was undertaken to determine the prevalence of HCV infection in non‐Hodgkin's lymphomas in patients affected by other haematological malignancies and in the general population of the same geographical area in the cohort study called the Dyonisos project.